We are live on ! Find out more
PIMJS

PKO Investment Management Joint-Stock Portfolio holdings

AUM $1.38B
1-Year Est. Return 59.54%
This Fund
S&P 500
This Quarter Est. Return
+30.43%
1 Year Est. Return
+59.54%
3 Year Est. Return
+124.73%
5 Year Est. Return
+130.21%
10 Year Est. Return
+742.49%
AUM
$1.38B
AUM Growth
+$188M
Cap. Flow
+$42.4M
Cap. Flow %
3.08%
Top 10 Hldgs %
37.86%
Holding
242
New
22
Increased
67
Reduced
67
Closed
14

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$8.84M
2
SNDK
Sandisk
SNDK
+$6.42M
3
AEM icon
Agnico Eagle Mines
AEM
+$4.71M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$4.26M
5
PEP icon
PepsiCo
PEP
+$4.15M

Sector Composition

Rank Sector Weight
1 Technology 33.58%
2 Materials 17.09%
3 Consumer Discretionary 7.82%
4 Healthcare 7.45%
5 Communication Services 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQV icon
201
IQVIA
IQV
$40.7B
$483K 0.04%
2,500
+300
+14% +$52.3K
TEVA icon
202
Teva Pharmaceuticals
TEVA
$40.4B
$474K 0.03%
14,000
+3,000
+27% +$99.9K
WAT icon
203
Waters Corp
WAT
$37.3B
$469K 0.03%
1,250
+50
+4% +$17.1K
NTRA icon
204
Natera
NTRA
$36.4B
$434K 0.03%
1,600
H icon
205
Hyatt Hotels
H
$17.5B
$426K 0.03%
2,200
RVMD icon
206
Revolution Medicines
RVMD
$38.5B
$412K 0.03%
2,200
+700
+47% +$102K
BIIB icon
207
Biogen
BIIB
$30.9B
$411K 0.03%
1,900
+600
+46% +$115K
MGM icon
208
MGM Resorts International
MGM
$11.7B
$406K 0.03%
8,500
ZTS icon
209
Zoetis
ZTS
$32.7B
$395K 0.03%
5,500
-1,500
-21% -$141K
VEEV icon
210
Veeva Systems
VEEV
$33.8B
$355K 0.03%
2,000
RMD icon
211
ResMed
RMD
$31.1B
$351K 0.03%
1,800
CNC icon
212
Centene
CNC
$30.5B
$321K 0.02%
5,000
MTD icon
213
Mettler-Toledo International
MTD
$28.1B
$319K 0.02%
250
NIO icon
214
NIO
NIO
$11.9B
$304K 0.02%
60,000
SIG icon
215
Signet Jewelers
SIG
$3.84B
$302K 0.02%
3,500
WST icon
216
West Pharmaceutical
WST
$23.7B
$287K 0.02%
800
LH icon
217
Labcorp
LH
$25.2B
$280K 0.02%
1,000
UTHR icon
218
United Therapeutics
UTHR
$26.1B
$271K 0.02%
500
+200
+67% +$113K
ILMN icon
219
Illumina
ILMN
$29.5B
$264K 0.02%
1,500
INCY icon
220
Incyte
INCY
$25.8B
$238K 0.02%
2,100
NBIX icon
221
Neurocrine Biosciences
NBIX
$18.2B
$236K 0.02%
1,400
ZBH icon
222
Zimmer Biomet
ZBH
$18.8B
$215K 0.02%
2,500
COO icon
223
Cooper Companies
COO
$14.2B
$215K 0.02%
3,000
DGX icon
224
Quest Diagnostics
DGX
$26B
$212K 0.02%
1,000
MDLN
225
Medline Inc
MDLN
$33.9B
$197K 0.01%
+5,000
New +$201K

Similar funds

PKO Investment Management Joint-Stock's Q2 2026 Portfolio in Review

As of Q2 2026, PKO Investment Management Joint-Stock held 242 positions worth $1.38B, up 16% from $1.19B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

PKO Investment Management Joint-Stock deployed $42.4M of net new capital in Q2 2026, opening 22 new positions and adding to 67 existing holdings. Its largest new stake was Sandisk: 4,500 shares worth $10.2M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 25% a quarter earlier, followed by Materials and Consumer Discretionary.

On the sell side, the largest reduction was Marvell Technology, an estimated $4.47M trimmed.

  • PKO Investment Management Joint-Stock's largest Q2 2026 buy was Sandisk: 4,500 shares worth $10.2M.
  • PKO Investment Management Joint-Stock added most to NVIDIA in Q2 2026, an estimated $8.84M increase.
  • PKO Investment Management Joint-Stock's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $4.47M.
  • PKO Investment Management Joint-Stock fully exited Mondelez International in Q2 2026, selling an estimated $2.08M.
  • PKO Investment Management Joint-Stock's ten largest holdings make up 38% of its $1.38B portfolio in Q2 2026.
  • PKO Investment Management Joint-Stock opened 22 new positions and closed 14 in Q2 2026.
  • PKO Investment Management Joint-Stock's portfolio value rose 16% quarter-over-quarter to $1.38B.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.